M. Ocak Et Al. , "Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative," Nuclear Medicine and Biology , vol.38, no.2, pp.171-179, 2011
Ocak, M. Et Al. 2011. Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative. Nuclear Medicine and Biology , vol.38, no.2 , 171-179.
Ocak, M., Helbok, A., von Guggenberg, E., Ozsoy, Y., Kabasakal, L., Kremser, L., ... Decristoforo, C.(2011). Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative. Nuclear Medicine and Biology , vol.38, no.2, 171-179.
Ocak, Emine Et Al. "Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative," Nuclear Medicine and Biology , vol.38, no.2, 171-179, 2011
Ocak, Emine M. Et Al. "Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative." Nuclear Medicine and Biology , vol.38, no.2, pp.171-179, 2011
Ocak, M. Et Al. (2011) . "Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative." Nuclear Medicine and Biology , vol.38, no.2, pp.171-179.
@article{article, author={Emine Meltem OCAK DEMİRCİ Et Al. }, title={Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative}, journal={Nuclear Medicine and Biology}, year=2011, pages={171-179} }